In a CML mouse model, the loss of kindlin-3 abrogates integrin-mediated adhesion of leukemia stem cells to the bone marrow niche, triggering their release into circulation and impairing their proliferation, survival, and metastatic dissemination18. The gene discussed is FERMT3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.